These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 28482962)

  • 1. Isoniazid-monoresistant tuberculosis is associated with poor treatment outcomes in Durban, South Africa.
    van der Heijden YF; Karim F; Mufamadi G; Zako L; Chinappa T; Shepherd BE; Maruri F; Moosa MS; Sterling TR; Pym AS
    Int J Tuberc Lung Dis; 2017 Jun; 21(6):670-676. PubMed ID: 28482962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isoniazid Monoresistance and Rate of Culture Conversion among Patients in the State of Georgia with Confirmed Tuberculosis, 2009-2014.
    Salindri AD; Sales RF; DiMiceli L; Schechter MC; Kempker RR; Magee MJ
    Ann Am Thorac Soc; 2018 Mar; 15(3):331-340. PubMed ID: 29131662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of isoniazid monoresistant tuberculosis with drug-susceptible tuberculosis and multidrug-resistant tuberculosis.
    Fox L; Kramer MR; Haim I; Priess R; Metvachuk A; Shitrit D
    Eur J Clin Microbiol Infect Dis; 2011 Jul; 30(7):863-7. PubMed ID: 21431989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical characteristics and treatment outcomes of patients with isoniazid-monoresistant tuberculosis.
    Cattamanchi A; Dantes RB; Metcalfe JZ; Jarlsberg LG; Grinsdale J; Kawamura LM; Osmond D; Hopewell PC; Nahid P
    Clin Infect Dis; 2009 Jan; 48(2):179-85. PubMed ID: 19086909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics and treatment outcomes of patients with low- and high-concentration isoniazid-monoresistant tuberculosis.
    Wang TY; Lin SM; Shie SS; Chou PC; Huang CD; Chung FT; Kuo CH; Chang PJ; Kuo HP
    PLoS One; 2014; 9(1):e86316. PubMed ID: 24466020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes among tuberculosis patients with isoniazid resistance in Georgia, 2007-2009.
    Gegia M; Cohen T; Kalandadze I; Vashakidze L; Furin J
    Int J Tuberc Lung Dis; 2012 Jun; 16(6):812-6. PubMed ID: 22507372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of tuberculosis among contacts of isoniazid-resistant and isoniazid-susceptible cases.
    Tuberculosis Research Centre, Indian Council of Medical Research (ICMR), Chennai, India
    Int J Tuberc Lung Dis; 2011 Jun; 15(6):782-8. PubMed ID: 21575299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multidrug- and isoniazid-resistant tuberculosis in three high HIV burden African regions.
    Sanchez-Padilla E; Ardizzoni E; Sauvageot D; Ahoua L; Martin A; Varaine F; Adatu-Engwau F; Akeche G; Salaniponi F; Bonnet M
    Int J Tuberc Lung Dis; 2013 Aug; 17(8):1036-42. PubMed ID: 23827027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. M. tuberculosis genotypic diversity and drug susceptibility pattern in HIV-infected and non-HIV-infected patients in northern Tanzania.
    Kibiki GS; Mulder B; Dolmans WM; de Beer JL; Boeree M; Sam N; van Soolingen D; Sola C; van der Zanden AG
    BMC Microbiol; 2007 May; 7():51. PubMed ID: 17540031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tuberculosis drug resistance in Southern Mozambique: results of a population-level survey in the district of Manhiça.
    Valencia S; Respeito D; Blanco S; Ribeiro RM; López-Varela E; Sequera VG; Saavedra B; Mambuque E; Morillo MG; Bulo H; Cobelens F; Macete E; Alonso PL; Caminero JA; García-Basteiro AL
    Int J Tuberc Lung Dis; 2017 Apr; 21(4):446-451. PubMed ID: 28284261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isoniazid (INH) mono-resistance and tuberculosis (TB) treatment success: analysis of European surveillance data, 2002 to 2014.
    Karo B; Kohlenberg A; Hollo V; Duarte R; Fiebig L; Jackson S; Kearns C; Ködmön C; Korzeniewska-Kosela M; Papaventsis D; Solovic I; van Soolingen D; van der Werf MJ
    Euro Surveill; 2019 Mar; 24(12):. PubMed ID: 30914081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular and phenotypic characterisation of Mycobacterium tuberculosis resistant to anti-tuberculosis drugs.
    Imperiale BR; Zumárraga MJ; Di Giulio AB; Cataldi AA; Morcillo NS
    Int J Tuberc Lung Dis; 2013 Aug; 17(8):1088-93. PubMed ID: 23827034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rise in rifampicin-monoresistant tuberculosis in Western Cape, South Africa.
    Mukinda FK; Theron D; van der Spuy GD; Jacobson KR; Roscher M; Streicher EM; Musekiwa A; Coetzee GJ; Victor TC; Marais BJ; Nachega JB; Warren RM; Schaaf HS
    Int J Tuberc Lung Dis; 2012 Feb; 16(2):196-202. PubMed ID: 22236920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbiological investigation for tuberculosis among HIV-infected children in Soweto, South Africa.
    Fairlie L; Muchiri E; Beylis CN; Meyers T; Moultrie H
    Int J Tuberc Lung Dis; 2014 Jun; 18(6):676-81. PubMed ID: 24903938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rifampin monoresistant tuberculosis and HIV comorbidity in California, 1993-2008: a retrospective cohort study.
    Prach LM; Pascopella L; Barry PM; Flood J; Porco TC; Hopewell PC; Metcalfe JZ
    AIDS; 2013 Oct; 27(16):2615-22. PubMed ID: 23842135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid genotypic assays to identify drug-resistant Mycobacterium tuberculosis in South Africa.
    Evans J; Stead MC; Nicol MP; Segal H
    J Antimicrob Chemother; 2009 Jan; 63(1):11-6. PubMed ID: 18940875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isoniazid Resistance and Dosage as Treatment for Patients with Tuberculosis.
    Nagel S; Streicher EM; Klopper M; Warren RM; Van Helden PD
    Curr Drug Metab; 2017; 18(11):1030-1039. PubMed ID: 29086682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isoniazid-monoresistant tuberculosis in the United States, 1993 to 2003.
    Hoopes AJ; Kammerer JS; Harrington TA; Ijaz K; Armstrong LR
    Arch Intern Med; 2008 Oct; 168(18):1984-92. PubMed ID: 18852399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk Factors for and Trends in Isoniazid Monoresistance at Diagnosis of Tuberculosis-United States, 1993-2016.
    Iqbal SA; Armstrong LR; Kammerer JS; Truman BI
    J Public Health Manag Pract; 2021 Jul-Aug 01; 27(4):E162-E172. PubMed ID: 31688735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.